Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Acq. announced
|
|
ASSEMBLY BIOSCIENCES, INC. (ASMB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| White Nicole S (Chief Manufacturing Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 10,000 shares
@ $0
Sold 1,891 shares
@ $0.7953, valued at
$1.5k
|
|
| 10/04/2023 |
4
| Delaney William E IV (Chief Scientific Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 10,000 shares
@ $0
Sold 1,891 shares
@ $0.7953, valued at
$1.5k
|
|
| 10/04/2023 |
4
| Okazaki Jason A (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 12,500 shares
@ $0
Sold 2,363 shares
@ $0.7953, valued at
$1.9k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/29/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/03/2023 |
4
| Delaney William E IV (Chief Scientific Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Sold 9,461 shares
@ $1.0879, valued at
$10.3k
|
|
| 08/03/2023 |
4
| Okazaki Jason A (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Sold 11,827 shares
@ $1.0879, valued at
$12.9k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2023 |
4
| Delaney William E IV (Chief Scientific Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Sold 4,232 shares
@ $0.9561, valued at
$4k
|
|
| 05/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/30/2023 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
| 05/30/2023 |
4
| McHutchison John G (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
| 05/30/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"AMENDMENT NO. 6 TO ASSEMBLY BIOSCIENCES, INC. 2018 STOCK INCENTIVE PLAN Assembly Biosciences, Inc., a Delaware corporation adopted the 2018 Stock Incentive Plan on May 30, 2018, which was amended by Amendment No. 1 to Assembly Biosciences, Inc. 2018 Stock Incentive Plan effective as of May 17, 2019, by Omnibus Amendment to Assembly Biosciences, Inc. Stock Plans effective as of March 11, 2020, by Amendment No. 3 effective as of June 11, 2020, by Amendment No. 4 effective as of May 20, 2021 and Amendment No. 5 effective as of May 25, 2022 . Prior to this Amendment No. 6 to the Plan, the number of shares of Common Stock, par value $0.001 per share, reserved under the Plan was 8,600,000. The Board of Directors of the Company may, with stockholder approval, amend the Plan to increase the number..." |
|
| 05/30/2023 |
4
| Mahony Susan (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
| 05/30/2023 |
4
| Johnson-Pratt Lisa (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
| 05/30/2023 |
4
| Houghton Michael (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
| 05/24/2023 |
4
| McHutchison John G (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 117,500 shares
@ $0
Sold 25,972 shares
@ $1.0403, valued at
$27k
|
|
| 05/24/2023 |
4
| Bjorkquist Jeanette M (Principal Accounting Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 1,500 shares
@ $0
Sold 274 shares
@ $1.0403, valued at
$285 |
|
| 05/24/2023 |
4
| Delaney William E IV (Chief Scientific Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 35,000 shares
@ $0
Sold 6,561 shares
@ $1.0403, valued at
$6.8k
|
|
| 05/24/2023 |
4
| Okazaki Jason A (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 35,000 shares
@ $0
Sold 6,561 shares
@ $1.0403, valued at
$6.8k
|
|
| 05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|
|
|